American International Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-450,065
Closed -$4.74M 2172
2024
Q1
$4.74M Buy
450,065
+444,212
+7,589% +$4.79M 0.02% 751
2023
Q4
$65.7K Sell
5,853
-19
-0.3% -$185 ﹤0.01% 2749
2023
Q3
$68.6K Sell
5,872
-1,813,232
-100% -$20.5M ﹤0.01% 2721
2023
Q2
$18.3M Buy
1,819,104
+4,407
+0.2% +$39.4K 0.11% 146
2023
Q1
$13.4M Hold
1,814,697
0.09% 226
2022
Q4
$14.5M Hold
1,814,697
0.1% 181
2022
Q3
$5.84M Hold
1,814,697
0.04% 592
2022
Q2
$7.39M Hold
1,814,697
0.05% 513
2022
Q1
$8.96M Buy
+1,814,697
New +$12M 0.05% 520

Other funds holding ROIV

American International Group's ROIV Position: Q2 2024 in Review

American International Group sold out of Roivant Sciences (ROIV) in Q2 2024, closing a stake of 450,065 shares — an estimated $4.74M sold.

American International Group first reported a position in ROIV in Q1 2022 and held it in 9 quarters. The position peaked at $18.3M in Q2 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q2 2024.

  • American International Group reported no remaining Roivant Sciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 450,065 Roivant Sciences shares in Q2 2024, an estimated $4.74M.
  • American International Group first reported a position in Roivant Sciences in Q1 2022 and held it in 9 quarters.
  • American International Group's Roivant Sciences position peaked at $18.3M in Q2 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.